Vaccines | Tenderlake

Vaccines

Contract Value:
EUR 2M - 2M
Notice Type:
Contract award notice
Published Date:
23 December 2022
Closing Date:
Location(s):
FI SUOMI / FINLAND (FI Finland/SUOMI / FINLAND)
FI1 MANNER-SUOMI (FI Finland/SUOMI / FINLAND)
FI1B Helsinki-Uusimaa (FI Finland/SUOMI / FINLAND)
Description:
Hepatitis B Vaccine (HBV) for children and adults 2023-2025 (2025-2026, 2026-2027)

The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish institute for health and welfare (hereinafter "THL" or “Customer” ) request your tender for Hepatitis B Vaccine belonging to the National Vaccination Programme in Finland.

The contract period is about two years 2023-2025. The procurement contains two options to extend the contract for the periods 2025-2026 and 2026-2027.

The purpose of STM and the Customer is to procure Hepatitis B Vaccines for children and adults required for the National Vaccination Programme in Finland for risk groups. The tendered vaccine for children must be suitable for children aged 0-15 years. The tendered vaccine for adolescents and adults must be suitable for people aged 16 years and over.

More information about National Vaccination Programme and vaccinations can be found on the website of the Finnish Institute for Health and Welfare: https://thl.fi/en/web/infectious-diseases-and-vaccinations/vaccines-a-to-z/hepatitis-vaccines/hepatitis-b-vaccine

The Customer will implement the procurement on behalf of STM. The roles of STM and Customer are described in more detail in section "Presentation of the contracting authority".

Awarded to:
Hepatitis B Vaccine (HBV) for children and adults 2023-2025 (2025-2026, 2026-2027)
GlaxoSmithKline Oy, Espoo (FI)
Download full details as .pdf
The Buyer:
Ministry of Social Affairs and Health
CPV Code(s):
33651600 - Vaccines